COMMUNIQUÉS West-GlobeNewswire

CV Sciences, Inc. Reports Third Quarter 2018 Financial Results

07/11/2018 - 14:45

Record Sales and Gross Profit Lead Strong Quarter for CVSI 10% Sequential Sales Increase Management to Host Third Quarter 2018 Financial Results Conference Call on November 7, 2018 at 4:15pm ET LAS VEGAS, Nov. 07, 2018 [...]

Daxor Corporation Selected for U.S. Army Contract to Develop a Blood Volume Analyzer for Improvement of Combat Casualty Care

07/11/2018 - 14:30

NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]

Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation

07/11/2018 - 14:30

MINNEAPOLIS, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

Onconova Welcomes Richard (Ric) Woodman, M.D., as Chief Medical Officer (CMO)

07/11/2018 - 14:30

Dr. Woodman is appointed CMO and Senior Vice President of Research & Development, joining Onconova after multiple accomplishments at Novartis Other recent hires in Clinical and Regulatory Affairs strengthen the [...]

Bellerophon Provides Business Update and Reports Third Quarter 2018 Financial Results

07/11/2018 - 14:30

WARREN, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and reported [...]

Kane Biotech Senior Management Purchases 1.9 Million Shares

07/11/2018 - 14:30

WINNIPEG, Manitoba, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), today announced that Marc Edwards, Chief Executive Officer, and Ray Dupuis, Chief [...]

Minerva Neurosciences to Present at Jefferies London Healthcare Conference on November 14, 2018

07/11/2018 - 14:30

WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system [...]

Profound Medical to Present at the Stifel 2018 Healthcare Conference

07/11/2018 - 14:30

TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

Crown Bioscience présentera son expertise scientifique au EORTC-NCI-AACR

07/11/2018 - 14:18

Nouvelles données de modèles publiées, y compris les modèles cibles PDX du cancer de la prostate et les modèles cibles humanisés, pour l'évaluation d'inhibiteurs combinés de points de contrôle humains SAN DIEGO, 07 nov [...]

Chimerix to Present at the Stifel 2018 Healthcare Conference

07/11/2018 - 14:14

DURHAM, N.C., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that M. Michelle [...]

MyoKardia to Present at the Credit Suisse 27th Annual Healthcare Conference

07/11/2018 - 14:01

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today [...]

Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Prevention of Ischemia and Reperfusion Injury from Organ Transplantation

07/11/2018 - 14:00

TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE:31R) ("Revive" or the “Company”) , a specialty cannabis company focused on the research, development and [...]

Kezar Life Sciences to Present at Jefferies 2018 London Healthcare Conference

07/11/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]

iTeos Therapeutics to Participate in Upcoming Conferences in November

07/11/2018 - 14:00

iTeos Therapeutics to Participate in Upcoming Conferences in November Gosselies, Belgium – November 7, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced that [...]

Forty Seven Inc. to Present at the Credit Suisse 27th Annual Healthcare Conference

07/11/2018 - 14:00

MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV) a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]

Evelo Biosciences to Present at Upcoming Investor Conferences in November

07/11/2018 - 14:00

CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing monoclonal microbials designed to act on the gut-body network for [...]

resTORbio to Present at Upcoming Investor Conferences in November

07/11/2018 - 14:00

BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]

Zogenix to Present at Stifel 2018 Healthcare Conference

07/11/2018 - 14:00

EMERYVILLE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]

BrainStorm Cell Therapeutics to Present at November Clinical and Investor Conferences

07/11/2018 - 14:00

Highlights Preclinical Research and Continued Progress of NurOwn® Platform in ALS Pivotal Trial NEW YORK and PETACH TIKVAH, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a [...]